Literature DB >> 16940434

Soluble guanylyl cyclase activation promotes angiogenesis.

Anastasia Pyriochou1, Dimitris Beis, Vasiliki Koika, Christos Potytarchou, Evangelia Papadimitriou, Zongmin Zhou, Andreas Papapetropoulos.   

Abstract

Soluble guanylyl cyclase (sGC) is a cGMP-generating enzyme carrying a heme prosthetic group that functions as a nitric oxide (NO) sensor. sGC is present in most cells types, including the vascular endothelium, where its biological functions remain largely unexplored. Herein, we have investigated the role of sGC in angiogenesis and angiogenesis-related properties of endothelial cells (EC). Initially, we determined that sGC was present and enzymatically active in the chicken chorioallantoic membrane (CAM) during the days of maximal angiogenesis. In the CAM, inhibition of endogenous sGC inhibited neovascularization, whereas activation promoted neovessel formation. Using zebrafish as a model for vascular development, we did not detect any effect on vasculogenesis upon sGC blockade, but we did observe an abnormal angiogenic response involving the cranial and intersegmental vessels, as well as the posterior cardinal vein. In vitro, pharmacological activation of sGC or adenovirus-mediated sGC gene transfer promoted EC proliferation and migration, whereas sGC inhibition blocked tube-like network formation. In addition, sGC inhibition blocked the migratory response to vascular EC growth factor. Cells infected with sGC-expressing adenoviruses exhibited increased extracellular signal-regulated kinase 1/2 and p38 MAPK activation that was sensitive to sGC inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, suggesting that these mitogen-activated protein kinases are downstream effectors of sGC in EC. A functional role for p38 in cGMP-stimulated migration was demonstrated using SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole]; pharmacological inhibition of p38 attenuated BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4-ylamine] and sGC overexpression-induced EC mobilization. We conclude that sGC activation promotes the expression of angiogenesis-related properties by EC and that sGC might represent a novel target to modulate neovessel formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940434     DOI: 10.1124/jpet.106.108878

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  26 in total

1.  An in vivo chemical library screen in Xenopus tadpoles reveals novel pathways involved in angiogenesis and lymphangiogenesis.

Authors:  Roland E Kälin; Nadja E Bänziger-Tobler; Michael Detmar; André W Brändli
Journal:  Blood       Date:  2009-05-28       Impact factor: 22.113

2.  Type 5 phosphodiesterase expression is a critical determinant of the endothelial cell angiogenic phenotype.

Authors:  Bing Zhu; Li Zhang; Mikhail Alexeyev; Diego F Alvarez; Samuel J Strada; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-21       Impact factor: 5.464

3.  Phosphodiesterase 5 inhibitors augment UT-15C-stimulated ATP release from erythrocytes of humans with pulmonary arterial hypertension.

Authors:  Elizabeth A Bowles; Gina N Moody; Yashaswini Yeragunta; Alan H Stephenson; Mary L Ellsworth; Randy S Sprague
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

4.  Deficiency of endothelial nitric oxide signaling pathway exacerbates peritoneal fibrosis in mice.

Authors:  Hiroyuki Kadoya; Minoru Satoh; Hajime Nagasu; Tamaki Sasaki; Naoki Kashihara
Journal:  Clin Exp Nephrol       Date:  2014-09-13       Impact factor: 2.801

Review 5.  Heme-dependent and independent soluble guanylate cyclase activators and vasodilation.

Authors:  Fernanda B M Priviero; R Clinton Webb
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

6.  Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells.

Authors:  Natalia N Mendelev; Verietta S Williams; David A Tulis
Journal:  J Cardiovasc Pharmacol       Date:  2009-02       Impact factor: 3.105

7.  Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.

Authors:  Kalpana Mujoo; Vladislav G Sharin; Emil Martin; Byung-Kwon Choi; Courtney Sloan; Lubov E Nikonoff; Alexander Y Kots; Ferid Murad
Journal:  Nitric Oxide       Date:  2009-12-03       Impact factor: 4.427

8.  cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines.

Authors:  G Haramis; Z Zhou; A Pyriochou; M Koutsilieris; C Roussos; A Papapetropoulos
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

9.  Inhibition of soluble guanylyl cyclase by small molecules targeting the catalytic domain.

Authors:  Jagamya Vijayaraghavan; Kristopher Kramp; Michael E Harris; Focco van den Akker
Journal:  FEBS Lett       Date:  2016-10-04       Impact factor: 4.124

10.  Hematopoietic stem cell development is dependent on blood flow.

Authors:  Trista E North; Wolfram Goessling; Marian Peeters; Pulin Li; Craig Ceol; Allegra M Lord; Gerhard J Weber; James Harris; Claire C Cutting; Paul Huang; Elaine Dzierzak; Leonard I Zon
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.